Home  >  TopNews
you can get e-magazine links on WhatsApp.Click here
+ Font Resize -

Health ministry launches training programmes for accredited hospitals to adopt best pharmacovigilance practices

Shardul Nautiyal, Mumbai
Tuesday, October 31, 2017, 08:00 Hrs  [IST]

Health Ministry has rolled out a series of training programmes to provide a platform for the accredited hospitals to understand the systems and procedures involved in adverse drug reaction (ADR) reporting and related practices of pharmacovigilance.

Around 600 NABH accredited hospitals are envisaged to commence ADR reporting as part of Pharmacovigilance Programme of India (PvPI), as mandated by the health ministry.

Indian Pharmacopoeia Commission (IPC) has recently trained healthcare professionals of NABH accredited hospitals in Telangana and Andhra Pradesh to promote monitoring and reporting of Adverse Drug Reactions (ADRs). This is followed by IPC signing an Memorandum of Understanding (MoU) with NABH. IPC is the National Coordination Centre (NCC) for PvPI.

Pharmacovigilance (PV) is a science that relates to detection, assessment, understanding and prevention of adverse affects or any other drug related problem. To track ADRs in Indian population, Union health ministry launched PvPI which has outreach all over the country but only a small portion of healthcare professionals have formal training in PV.

This will also go hand-in-hand with IPC which has recently concluded "Skill Development Programme on Basics and Regulatory Aspects of Pharmacovigilance". The programme aims to enhance the knowledge and skill of qualified pharmacovigilance professionals working for ensuring better patient safety as per the requirement of Schedule Y of Drug and Cosmetics Act, 1940.

Young pharmacy, medical and paramedical professionals seeking career in pharmacovigilance and existing professionals in pharmacovigilance are being taught by renowned experts from government teaching and corporate hospitals, regulatory authority, WHO, pharmaceutical industries, academic and research institutions.

The skill development initiative will encourage process of creating a registry of skills, enable and mobilize a large number of healthcare professionals to take up training and acquire requisite skills for employment apart from capacity building and strengthening of Qualified Person for Pharmacovigilance (QPPv) as per the requirement of the schedule Y of D&C Act.

“Keeping in view the objective of bringing substantial improvement in the quality of pharmaceutical products, it has become imperative that all personnel employed in pharmaceutical manufacturing units shall undergo the certification programs developed by Life Science Skill Development Council (LSSSDC) and with effect from January 1, 2018, no person shall be employed in any pharmaceutical, bio-pharmaceutical manufacturing units unless he has obtained a formal degree in the relevant area, or has been certified by LSSSDC or equivalent organization in the area in which he has been deployed,” the DCGI circular then said.


Post Your commentsPOST YOUR COMMENT
* Name :     
* Email :    
  Website :  
riya patel Jan 8, 2018 5:30 PM
Great !! Pharmacovigilance, also known as drug safety, plays a vitally important role in assessing the risk/benefit of pharmaceutical products and ensuring that they are safe for use in patients. However ... They are also good companies for career development, offering training to case processors in signal detection.
Copyright © 2016 Saffron Media Pvt. Ltd |